Solving Healthcare’s Unique Cybersecurity Risks

The risks of cyberattacks on hospitals and other healthcare settings was already high pre-pandemic, as these institutions work with sensitive data, like patient information. But attackers never let an opportunity go to waste, and they’ve already targeted the manufacturing and distribution of COVID-19 vaccines—including a known attack on Pfizer.

Read More »

When Face-to-Face Isn’t an Option

For many organizations, this has meant a shift to telehealth. This technology has been available for some time, of course, but was not nearly as widely used as it is today. How can providers make sure they have the know-how to help their patients maintain their care, live healthy lives, and get the medications and treatments they need, all while working with them remotely?

Read More »

Top 10 Medical Technology Hazards of 2021 Show Impact of Pandemic

Complexity of managing medical devices with COVID-19 emergency use authorization (EUA) are the leading medical technology hazard for 2021, according to the ECRI Institute. Other top concerns of ECRI’s latest such report include reliance on consumer-grade products for important healthcare decisions and hasty deployment of UV disinfection devices, which can reduce effectiveness and increase exposure risks.

Read More »

ECRI Q&A Provides Lessons Learned on Vaccine Rollout

You will need space to take a patient history (including any previous allergic or anaphylactic reactions to food, drugs, or insects), to administer the vaccine, to provide at least 15 minutes of observation for adverse reactions afterward, and an area to care for anyone who does have a reaction—all while maintaining the same social-distancing and infectious-disease precautions you’ve had since the pandemic began.

Read More »

Missed Cancer Screening During Coronavirus Pandemic Raises Alarm

People have been deferring care during the pandemic due to fear of contracting the coronavirus in healthcare settings. For five kinds of cancer, reduced cancer screening linked to the coronavirus pandemic has likely led to thousands of delayed cancer diagnoses, according to an IQVIA Institute report. For the three-month period ending June 5, 2020, the IQVIA Institute estimates there could have been more than 80,000 delayed positive diagnoses for breast, cervical, colorectal, lung, and prostate cancer.

Read More »